DOJ Fights Bid To Pause Piece Of Amedisys Merger Case

By Matthew Perlman · March 5, 2025, 3:25 PM EST

The U.S. Department of Justice is opposing a bid from Amedisys to pause allegations that it shirked its merger filing requirements until after a trial on UnitedHealth's acquisition of the home...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

United States of America et al v. UnitedHealth Group Incorporated et al

Case Number

Court

Maryland

Nature of Suit

Anti-Trust

Date Filed

November 12, 2024

Recent Articles By Matthew

March 07, 2025
Ohio, PBMs Say High Court Ruling Didn't End Pricing Appeal
March 06, 2025
FTC Challenges PE Firm's Medical Device Coatings Deal
March 04, 2025
PBMs Ask 8th Circ. To Pause FTC's Insulin Pricing Case
March 03, 2025
Credit Bureaus Look To Duck Renewed Medical Debt Claims
February 28, 2025
Robotic Surgery Co. Appealing Tossed Intuitive Antitrust Case
February 06, 2025
UnitedHealth Drops Bid To Toss Home Health Deal Challenge
January 28, 2025
4th Circ. Raises Questions Over Health Data Access Order
January 28, 2025
Minn. AG Settles Novo Nordisk Insulin Claims With Price Cap
January 17, 2025
MultiPlan Wants Antitrust Claims Over Pricing Tools Tossed
January 16, 2025
Merck Defends 3rd Circ. Win In Mumps Vaccine Antitrust Case